GeneDx Holdings Corp. (WGS) Profit Margins
Over the twelve months to 2026-06-30, GeneDx Holdings Corp. (WGS) had gross margin 69.4%, operating margin -20.3%, net margin -23.4%, free cash flow margin -16.7%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
WGSGeneDx Holdings Corp.Follow WGS — free
—
Price chart with a free account
- Market cap
- 1.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 26 Oct, in 2 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Gross margin | -7.8% | -11.4% | 44.4% | 63.6% | 69.7% | 69.4% | |
| Operating margin | -210.3% | -284.5% | -89.2% | -7.6% | -3.1% | -20.3% | |
| Net margin | -115.6% | -233.9% | -86.8% | -17.1% | -4.9% | -23.4% | |
| FCF margin | -99.5% | -139.0% | -91.8% | -11.1% | 3.3% | -16.7% |
USD millions · SEC XBRL
GeneDx Holdings Corp. — questions
- What is GeneDx Holdings Corp.'s gross margin?
- 69.4% over the twelve months to 2026-06-30.
- What is GeneDx Holdings Corp.'s operating margin?
- -20.3% over the twelve months to 2026-06-30.
- What is GeneDx Holdings Corp.'s net profit margin?
- -23.4% over the twelve months to 2026-06-30.
Every figure on this page comes from GeneDx Holdings Corp.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.